annual cash & cash equivalents:
$626.90M-$11.18M(-1.75%)Summary
- As of today (September 10, 2025), XENE annual cash & cash equivalents is $626.90 million, with the most recent change of -$11.18 million (-1.75%) on December 31, 2024.
- During the last 3 years, XENE annual cash & cash equivalents has risen by +$75.13 million (+13.62%).
- XENE annual cash & cash equivalents is now -1.75% below its all-time high of $638.08 million, reached on December 31, 2023.
Performance
XENE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$487.55M-$62.08M(-11.30%)Summary
- As of today (September 10, 2025), XENE quarterly cash & cash equivalents is $487.55 million, with the most recent change of -$62.08 million (-11.30%) on June 1, 2025.
- Over the past year, XENE quarterly cash & cash equivalents has dropped by -$233.99 million (-32.43%).
- XENE quarterly cash & cash equivalents is now -38.15% below its all-time high of $788.24 million, reached on June 30, 2022.
Performance
XENE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XENE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.8% | -32.4% |
| 3 y3 years | +13.6% | -38.1% |
| 5 y5 years | +2432.4% | +140.5% |
XENE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.8% | +13.6% | -38.1% | at low |
| 5 y | 5-year | -1.8% | +2432.4% | -38.1% | +175.4% |
| alltime | all time | -1.8% | +3567.2% | -38.1% | +3219.3% |
XENE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $487.55M(-11.3%) |
| Mar 2025 | - | $549.63M(-12.3%) |
| Dec 2024 | $626.90M(-1.8%) | $626.90M(-4.1%) |
| Sep 2024 | - | $654.01M(-9.4%) |
| Jun 2024 | - | $721.53M(+3.1%) |
| Mar 2024 | - | $699.60M(+9.6%) |
| Dec 2023 | $638.08M(+7.8%) | $638.08M(+21.2%) |
| Sep 2023 | - | $526.67M(-2.4%) |
| Jun 2023 | - | $539.60M(+2.4%) |
| Mar 2023 | - | $527.04M(-11.0%) |
| Dec 2022 | $592.09M(+7.3%) | $592.09M(-7.2%) |
| Sep 2022 | - | $638.18M(-19.0%) |
| Jun 2022 | - | $788.24M(+46.5%) |
| Mar 2022 | - | $537.94M(-2.5%) |
| Dec 2021 | $551.77M(+211.7%) | $551.77M(+121.0%) |
| Sep 2021 | - | $249.63M(-4.2%) |
| Jun 2021 | - | $260.52M(-5.2%) |
| Mar 2021 | - | $274.70M(+55.2%) |
| Dec 2020 | $177.00M(+615.0%) | $177.00M(-7.3%) |
| Sep 2020 | - | $190.93M(-5.8%) |
| Jun 2020 | - | $202.75M(-11.7%) |
| Mar 2020 | - | $229.67M(+827.8%) |
| Dec 2019 | $24.75M | $24.75M(-34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $37.67M(+1.6%) |
| Jun 2019 | - | $37.08M(-28.9%) |
| Mar 2019 | - | $52.18M(-23.0%) |
| Dec 2018 | $67.75M(+230.7%) | $67.75M(-23.0%) |
| Sep 2018 | - | $87.96M(+85.4%) |
| Jun 2018 | - | $47.44M(+175.8%) |
| Mar 2018 | - | $17.20M(-16.0%) |
| Dec 2017 | $20.49M(+19.8%) | $20.49M(+39.5%) |
| Sep 2017 | - | $14.69M(-36.4%) |
| Jun 2017 | - | $23.09M(+14.5%) |
| Mar 2017 | - | $20.16M(+17.9%) |
| Dec 2016 | $17.09M(-70.9%) | $17.09M(-68.4%) |
| Sep 2016 | - | $54.13M(+53.7%) |
| Jun 2016 | - | $35.21M(-37.2%) |
| Mar 2016 | - | $56.06M(-4.4%) |
| Dec 2015 | $58.65M(-18.6%) | $58.65M(-10.4%) |
| Sep 2015 | - | $65.47M(+1.7%) |
| Jun 2015 | - | $64.35M(-2.4%) |
| Mar 2015 | - | $65.92M(-8.5%) |
| Dec 2014 | $72.03M(+89.8%) | $72.03M(+113.5%) |
| Sep 2014 | - | $33.73M(-3.9%) |
| Jun 2014 | - | $35.09M(-7.5%) |
| Dec 2013 | $37.95M(-36.9%) | $37.95M |
| Dec 2012 | $60.16M | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual cash & cash equivalents year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly cash & cash equivalents year-on-year change?
What is Xenon Pharmaceuticals Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of XENE is $626.90M
What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual cash & cash equivalents is $638.08M
What is Xenon Pharmaceuticals Inc. annual cash & cash equivalents year-on-year change?
Over the past year, XENE annual cash & cash equivalents has changed by -$11.18M (-1.75%)
What is Xenon Pharmaceuticals Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XENE is $487.55M
What is the all time high quarterly cash & cash equivalents for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly cash & cash equivalents is $788.24M
What is Xenon Pharmaceuticals Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, XENE quarterly cash & cash equivalents has changed by -$233.99M (-32.43%)